Elsevier’s Oncology Journal Network highlights

Welcome to our Elsevier’s Oncology Journal Network Highlights page. Here you can browse through the latest, cutting-edge oncology and cancer biology research, our topical article collections, and learn more about our Network offerings.

May recognises Brain Cancer, Bladder Cancer, and Melanoma and Skin Cancer Awareness Months.

• ●

  Brain Cancer

• ●

  Bladder Cancer

• ●

  Melanoma and Skin Cancer Cancer

Cancer Letters

• ●

  Exosomes; multifaceted nanoplatform for targeting brain cancers(se abre en una nueva pestaña/ventana)

• ●

  Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?(se abre en una nueva pestaña/ventana)

• ●

  Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model(se abre en una nueva pestaña/ventana)

Cancer Pathogenesis and Therapy

• ●

  Co-culture models for investigating cellular crosstalk in the glioma microenvironment(se abre en una nueva pestaña/ventana)

• ●

  Experimental models for cancer brain metastasis(se abre en una nueva pestaña/ventana)

• ●

  Biomaterial-based in vitro 3D modeling of glioblastoma multiforme(se abre en una nueva pestaña/ventana)

Clinical Imaging

• ●

  Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: Comparison with conventional MRI(se abre en una nueva pestaña/ventana)

• ●

  Meningiomas with brain edema: Radiological characteristics on MRI and review of the literature(se abre en una nueva pestaña/ventana)

• ●

  Cerebral hydatid disease: CT and MR findings(se abre en una nueva pestaña/ventana)

Clinics

• ●

  OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM)(se abre en una nueva pestaña/ventana)

Current Problems in Cancer

• ●

  Melanoma Brain Metastases: Is It Time to Reassess the Bias?(se abre en una nueva pestaña/ventana)

• ●

  ACR Appropriateness Criteria^®: Single Brain Metastasis (se abre en una nueva pestaña/ventana)

• ●

  Brain Tumor Stem Cells(se abre en una nueva pestaña/ventana)

Current Problems in Cancer: Case Reports

• ●

  Control of renal cell carcinoma brain metastases with cabozantinib following progression on immune checkpoint inhibitor therapy(se abre en una nueva pestaña/ventana)

• ●

  Clinically significant radiation necrosis following trastuzumab-deruxtecan and brain stereotactic radiosurgery: A case series in breast cancer patients(se abre en una nueva pestaña/ventana)

International Journal of Particle Therapy

• ●

  Estimating Potential Benefits to Neurocognition with Proton Therapy in Adults with Brain Tumors(se abre en una nueva pestaña/ventana)

International Journal of Radiation Oncology, Biology, and Physics

• ●

  Pencil Beam Scanning Proton Therapy for Pregnant Patients With Brain and Head and Neck Cancers(se abre en una nueva pestaña/ventana)

• ●

  Predictors of tumour dynamics over a 6-week course of concurrent chemoradiotherapy for glioblastoma and the impact on survival(se abre en una nueva pestaña/ventana)

• ●

  ClonoScreen3D – a novel three-dimensional clonogenic screening platform for identification of radiosensitizers for glioblastoma(se abre en una nueva pestaña/ventana)

• ●

  Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma(se abre en una nueva pestaña/ventana)

• ●

  Treatment Planning Expansions in Glioblastoma: How Less Can Be More(se abre en una nueva pestaña/ventana)

Journal of the National Cancer Center

• ●

  Precision based approach to tailoring radiotherapy in the multidisciplinary management of pediatric central nervous system tumors(se abre en una nueva pestaña/ventana)

Medical Dosimetry

• ●

  MRI-based treatment planning for brain stereotactic radiosurgery: Dosimetric validation of a learning-based pseudo-CT generation method - ScienceDirect(se abre en una nueva pestaña/ventana)

• ●

  Dosimetric Comparison Between 2-Dimensional Radiation Therapy and Intensity Modulated Radiation Therapy in Treatment of Advanced T-Stage Nasopharyngeal Carcinoma: To Treat Less or More in the Planning Organ-At-Risk Volume of the Brainstem and Spinal Cord(se abre en una nueva pestaña/ventana)

• ●

  Automatic planning on hippocampal avoidance whole-brain radiotherapy(se abre en una nueva pestaña/ventana)

Neoplasia

• ●

  Special Issue on Pediatric Brain Tumors(se abre en una nueva pestaña/ventana)

Radiation Medicine and Protection

• ●

  Survival and effective prognostic factors in lung cancer patients with brain metastases treated with whole brain radiotherapy(se abre en una nueva pestaña/ventana)

Translational Oncology

• ●

  Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15(se abre en una nueva pestaña/ventana)

• ●

  High Prevalence of Human Cytomegalovirus in Brain Metastases of Patients with Primary Breast and Colorectal Cancers(se abre en una nueva pestaña/ventana)

• ●

  Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma(se abre en una nueva pestaña/ventana)

Cancer Letters

• ●

  WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity(se abre en una nueva pestaña/ventana)

• ●

  TROP2 translation mediated by dual m6A/m7G RNA modifications promotes bladder cancer development(se abre en una nueva pestaña/ventana)

Cancer Pathogenesis and Therapy

• ●

  Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management(se abre en una nueva pestaña/ventana)

• ●

  Inaugurating a novel adjuvant therapy in urological cancers: Ferroptosis(se abre en una nueva pestaña/ventana)

• ●

  Role of T cells in cancer immunotherapy: Opportunities and challenges(se abre en una nueva pestaña/ventana)

Cancer Treatment and Research Communications

• ●

  Role of immunotherapy in bladder cancer(se abre en una nueva pestaña/ventana)

• ●

  Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experience(se abre en una nueva pestaña/ventana)

Clinical Genitourinary Cancer

• ●

  The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US Veterans Health Administration Study(se abre en una nueva pestaña/ventana)

• ●

  Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients(se abre en una nueva pestaña/ventana)

• ●

  Bladder Cancer and the Urinary Microbiome—New Insights and Future Directions: A Review(se abre en una nueva pestaña/ventana)

Clinical Imaging

• ●

  Comparison of different diagnostic methods for differentiating biliary atresia from idiopathic neonatal hepatitis(se abre en una nueva pestaña/ventana)

• ●

  Inguinoscrotal bladder herniation: Is CT a useful tool in diagnosis? (case report)(se abre en una nueva pestaña/ventana)

• ●

  Virtual cystoscopy in the evaluation of bladder tumors(se abre en una nueva pestaña/ventana)

Current Problems in Cancer

• ●

  Multimodal management of muscle-invasive bladder cancer(se abre en una nueva pestaña/ventana)

• ●

  Diagnosis and management of superficial bladder cancer(se abre en una nueva pestaña/ventana)

• ●

  The diagnostic and prognostic roles of serum irisin in bladder cancer(se abre en una nueva pestaña/ventana)

Current Problems in Cancer: Case Reports

• ●

  De novo angiosarcoma of the bladder: A case report(se abre en una nueva pestaña/ventana)

• ●

  Cutaneous metastasis from prostate cancer: A case report with literature review(se abre en una nueva pestaña/ventana)

• ●

  A case of severe interstitial cystitis associated with pembrolizumab(se abre en una nueva pestaña/ventana)

International Journal of Particle Therapy

• ●

  Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy—Phase 2 Trial Secondary Analysis(se abre en una nueva pestaña/ventana)

International Journal of Radiation Oncology, Biology, and Physics

• ●

  Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients(se abre en una nueva pestaña/ventana)

• ●

  Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study(se abre en una nueva pestaña/ventana)

• ●

  Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial(se abre en una nueva pestaña/ventana)

Journal of Geriatric Oncology

• ●

  How I treat bladder cancer in elderly patients(se abre en una nueva pestaña/ventana)

• ●

  Management of bladder cancer in older patients: Position paper of a SIOG Task Force(se abre en una nueva pestaña/ventana)

Medical Dosimetry

• ●

  Movements of the Prostate Due to Rectal and Bladder Distension: Implications for Radiotherapy(se abre en una nueva pestaña/ventana)

• ●

  The impact of daily bladder filling on small bowel dose for intensity modulated radiation therapy for cervical cancer(se abre en una nueva pestaña/ventana)

• ●

  Adjuvant radiation therapy for bladder cancer: A dosimetric comparison of techniques(se abre en una nueva pestaña/ventana)

Neoplasia

• ●

  Hsa_circ_0001583 fuels bladder cancer metastasis by promoting staphylococcal nuclease and tudor domain containing 1-mediated MicroRNA decay(se abre en una nueva pestaña/ventana)

• ●

  Therapeutic significance of ARID1A mutation in bladder cancer(se abre en una nueva pestaña/ventana)

Translational Oncology

• ●

  Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer(se abre en una nueva pestaña/ventana)

• ●

  Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer(se abre en una nueva pestaña/ventana)

• ●

  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen(se abre en una nueva pestaña/ventana)

Cancer Letters

• ●

  SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis(se abre en una nueva pestaña/ventana)

• ●

  Skin cancer prevention – Recent advances and unmet challenges(se abre en una nueva pestaña/ventana)

Cancer Pathogenesis and Therapy

• ●

  Autophagy as a targeted therapeutic approach for skin cancer: Evaluating natural and synthetic molecular interventions(se abre en una nueva pestaña/ventana)

• ●

  Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus(se abre en una nueva pestaña/ventana)

• ●

  Role of T cells in cancer immunotherapy: Opportunities and challenges(se abre en una nueva pestaña/ventana)

Cancer Treatment and Research Communications

• ●

  Mitochondria-targeted magnolol inhibits OXPHOS, proliferation, and tumor growth via modulation of energetics and autophagy in melanoma cells(se abre en una nueva pestaña/ventana)

Clinical Imaging

• ●

  MRI features of a primary thoracic epidural melanoma: a case report(se abre en una nueva pestaña/ventana)

• ●

  Ground-glass nodules found in two patients with malignant melanomas: different growth rate and different histology(se abre en una nueva pestaña/ventana)

• ●

  Neurocutaneous melanosis in children with giant congenital melanocytic nevi(se abre en una nueva pestaña/ventana)

Current Problems in Cancer

• ●

  Molecular Alternations in Uveal Melanoma(se abre en una nueva pestaña/ventana)

• ●

  The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study(se abre en una nueva pestaña/ventana)

Current Problems in Cancer: Case Reports

• ●

  Nivolumab induced immune mediated transverse myelitis in a patient with metastatic melanoma: The broad clinical spectrum of immune mediated neurologic disorders(se abre en una nueva pestaña/ventana)

• ●

  A case of severe interstitial cystitis associated with pembrolizumab(se abre en una nueva pestaña/ventana)

• ●

  Safety and feasibility of intrathecal pembrolizumab infusion in refractory triple negative breast cancer with leptomeningeal disease: A case report(se abre en una nueva pestaña/ventana)

International Journal of Particle Therapy

• ●

  Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis(se abre en una nueva pestaña/ventana)

International Journal of Radiation Oncology, Biology, and Physics

• ●

  Single-Masked Randomized Phase 2 Study Assessing 2 Forms of Hypofractionated Proton Therapy in Patients With Large Choroidal Melanomas(se abre en una nueva pestaña/ventana)

Journal of Geriatric Oncology

• ●

  Checkpoint inhibition and melanoma: Considerations in treating the older adult(se abre en una nueva pestaña/ventana)

• ●

  Immune checkpoint inhibitors in older adults with melanoma or cutaneous malignancies: The Wilmot Cancer Institute experience(se abre en una nueva pestaña/ventana)

• ●

  Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study(se abre en una nueva pestaña/ventana)

Journal of the American Academy of Dermatology

• ●

  Skin cancer: Primary, secondary, and tertiary prevention. Part I(se abre en una nueva pestaña/ventana)

• ●

  Bias in, bias out: Underreporting and underrepresentation of diverse skin types in machine learning research for skin cancer detection—A scoping review(se abre en una nueva pestaña/ventana)

• ●

  Melanoma: An update on systemic therapies(se abre en una nueva pestaña/ventana)

• ●

  Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: A nationwide cancer registry study(se abre en una nueva pestaña/ventana)

• ●

  Melanoma in skin of color: Part I. Epidemiology and clinical presentation(se abre en una nueva pestaña/ventana)

• ●

  Melanoma screening and public education for minority populations in the United States(se abre en una nueva pestaña/ventana)

JAAD International

• ●

  ChatGPT underperforms in triaging appropriate use of Mohs surgery for cutaneous neoplasms(se abre en una nueva pestaña/ventana)

• ●

  Merkel cell carcinoma: Epidemiology, disease presentation, and current clinical practice outcomes(se abre en una nueva pestaña/ventana)

• ●

  Disparities in access for melanoma screening by region, specialty, and insurance: A cross-sectional audit study(se abre en una nueva pestaña/ventana)

• ●

  Reproducibility of the histopathologic diagnosis of melanoma and related melanocytic lesions: Results from a testing study and a reference guide for providers(se abre en una nueva pestaña/ventana)

Medical Dosimetry

• ●

  Ion therapy for uveal melanoma in new human eye phantom based on GEANT4 toolkit(se abre en una nueva pestaña/ventana)

• ●

  Dosimetric comparison and secondary malignancy risk estimation for linac-based and robotic stereotactic radiotherapy in uveal melanoma(se abre en una nueva pestaña/ventana)

• ●

  Review of the Poster “Dosimetric Comparison of Gamma Knife Radiosurgery vs. 125I Plaque Brachytherapy in a Cohort of Choroidal Melanomas”(se abre en una nueva pestaña/ventana)

Neoplasia

• ●

  Altered endosomal-lysosomal biogenesis in melanoma(se abre en una nueva pestaña/ventana)

• ●

  Slow-cycling murine melanoma cells display plasticity and enhanced tumorigenicity in syngeneic transplantation assay(se abre en una nueva pestaña/ventana)

• ●

  S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas(se abre en una nueva pestaña/ventana)

Radiation Medicine and Protection

• ●

  Prevention and treatment for radiation-induced skin injury during radiotherapy(se abre en una nueva pestaña/ventana)

• ●

  RXRα agonist bexarotene attenuates radiation-induced skin injury by relieving oxidative stress(se abre en una nueva pestaña/ventana)

Elsevier’s Oncology Journal Network